Condition
Peripheral Blood Stem Cell Transplantation clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Peripheral Blood Stem Cell Transplantation clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Lower dose of cyclophosphamide for preventing complications after blood stem cell transplants
This study is testing if a lower dose of a medication called cyclophosphamide can help prevent complications after blood stem cell transplants for patients while keeping them safe and healthy.
-
Ruxolitinib and chidamide–intensified busulfan/cyclophosphamide conditioning for peripheral blood stem cell transplant
This trial tests whether adding ruxolitinib and chidamide to a busulfan/cyclophosphamide conditioning regimen helps people aged 12–65 with high‑risk B‑cell acute lymphoblastic leukemia who are receiving allogeneic peripheral blood stem cell transplants.
Related topics
Quick answers
How many Peripheral Blood Stem Cell Transplantation clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.